HCA Healthcare (HCA) Proxy Filing summary

Executive summary

• Annual meeting scheduled for April 23, 2026, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of eight directors is on the agenda, with board recommending a vote for all nominees.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026, recommended for approval.

• Advisory vote on executive compensation (say-on-pay) recommended for approval.

• Stockholder proposal for a report on healthcare consequences recommended against by the board.

• Stockholder proposal regarding shareholders' right to act by written consent recommended against by the board.

Board of directors and corporate governance

• Board recommends all director nominees for election at the annual meeting.

• Proxies are authorized to vote on any other business that may arise during the meeting.